e-Drug3D

1370

THONZONIUM


INN
THONZONIUM

cas 553-08-2
CLASS

ANTIINFECTIVES
SURFACE-ACTIVE AGENT THAT PROMOTES TISSUE CONTACT BY DISPERSION AND PENETRATION OF THE CELLULAR DEBRIS AND EXUDATE
MONO-CATIONIC DETERGENT

ROUTE (list)

OTIC

ATC code

PK parameters

Target

-

DrugCentral

Insulin-degrading enzyme UNIPROT P14735 IDE

Download SDF file 1-Hexadecanaminium, N-[2-[[(4-methoxyphenyl)methyl]-2-pyrimidinylamino]ethyl]-N,N-dimethyl-

Formula:
C32H55N4O

Calculated chemical properties:

MW 511.80
NB_atoms 37
XLogP 8.05
PSA 31.751
NB_HD 0
NB_HA 4
fsp3 0.69
Lipinski(0=no;1=yes) 0

FDA
NDA 050356 (label) INN (THONZONIUM BROMIDE) COLY-MYCIN S (ENDO PHARMS INC) APPROVAL= AP YEAR= 1962

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL